Concepedia

Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change

Adrian L. Lopresti, Michaël Maes, M J Meddens, Garth Maker, Eddy Arnoldussen, Peter D. Drummond

European Neuropsychopharmacology · 2014 · 97 citations · 28 references

References

28

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

David V. Sheehan · The Journal of Clinical Psychiatry · 1998 · 19.4K citations

Medicine, Behavioral Sciences, Psychiatry +14

The Inventory of Depressive Symptomatology (IDS): psychometric properties

A. John Rush, Christina M. Gullion, Monica Ramirez Basco et al. · Psychological Medicine · 1996 · 2.2K citations

Social Sciences, Psychiatry, Psychology +17

The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression.

Michaël Maes, Marta Kubera, Jean–Claude Leunis · PubMed · 2008 · 619 citations

Life Sciences, Immunology, Psychiatry +15

Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events

Victor L. Serebruany, Alexander H. Glassman, Alex I. Malinin et al. · Circulation · 2003 · 339 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial

Somlak Chuengsamarn, Suthee Rattanamongkolgul, Benjaluck Phonrat et al. · The Journal of Nutritional Biochemistry · 2013 · 313 citations

Medicine, Endocrinology, Pharmacology +12